Skip to main navigation
Intellia Therapeutics home page
  • Home
  • About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Scientific Publications & Presentations
    • Glossary
  • Programs & Pipeline
  • Patient Focus
    • Disease Focus
    • Patient Stories
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Presentation
    • Events
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Contact
menu
Intellia Therapeutics Head office building

SEC Filing
Details

investor relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Presentation
  • Events
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Analyst Coverage
  • Investor Resources

Document Details

Form
8-K
Filing Date
Sep 4, 2026
Document Date
Sep 4, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Quick
Links

RSS FEEDS
EMAIL ALERTS
PRINT PAGE

Footer Legal

  • Cookie Policy
  • Terms of Use
  • Privacy Policy
© 2026. Intellia Therapeutics, Inc.

Intellia Therapeutics and the Intellia Therapeutics logo are registred trademarks with the U.S. Patent & Trademark Offce.